This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Holroyde, C. P. Articles by Reichard, G. A. Search for Related Content PubMed PubMed Citation Articles by Holroyde, C. P. Articles by Reichard, G. A.

Altered Glucose Metabolism in Metastatic Carcinoma¹

Clinical Oncology Program and Division of Research, Lankenau Hospital, Philadelphia, Pennsylvania 19151

To evaluate the possible role of altered glucose metabolism in malignant cachexia, metabolic parameters including total glucose turnover, glucose oxidation, and Cori cycle activity were measured in fourteen patients with metastatic carcinoma. Eight patients with progressive weight loss (PWL) were compared to 6 without (controls). Cori cycle activity was significantly increased (p <0.02) in PWL patients, 90 mg/kg/hr (range, 22 to 193) compared to 18 mg/kg/hr (range, 13 to 24) in controls. Total glucose turnover was moderately increased in PWL patients, 196 mg/kg/hr compared to 110 mg/kg/hr in controls. Glucose oxidation was 62 mg/kg/hr versus 48 mg/kg/hr, and total caloric expenditure was 36 kcal/sq m/hr compared to 33 Kcal/sq m/hr. PWL patients were metabolically heterogenous and mean values are skewed by four patients with increased glucose turnover, oxidation, and markedly high recycling rates that were equivalent to total endogenous glucose turnover of a normal subject. Total caloric expenditure was greatest in three of the four patients with a marked increase in Cori cycle activity. Energy loss associated with a high rate of gluconeogenesis from lactate has been suggested as an explanation for increased energy expenditure in some cancer patients, thus contributing to mechanisms that promote weight loss.

¹ Supported in part by NIH Research Grants AM-13527, GM-21549, and HL-16654.

² To whom reprint requests should be addressed.

Received 7/21/75. Accepted 9/ 9/75.

This article has been cited by other articles:

				M. J. Delano and L. L. Moldawer The Origins of Cachexia in Acute and Chronic Inflammatory Diseases Nutr Clin Pract, February 1, 2006; 21(1): 68 - 81. [Abstract] [Full Text] [PDF]

				M. J. Tisdale Molecular Pathways Leading to Cancer Cachexia Physiology, October 1, 2005; 20(5): 340 - 348. [Abstract] [Full Text] [PDF]

				D. H. Esper and W. A. Harb The Cancer Cachexia Syndrome: A Review of Metabolic and Clinical Manifestations Nutr Clin Pract, August 1, 2005; 20(4): 369 - 376. [Abstract] [Full Text] [PDF]

				W. K. Chau, C. F. Yang, Y. H. Chou, and C. H. Ho Aggressive Undifferentiated Carcinoma of Unknown Primary Site Complicated by Lactic Acidosis After Bleeding: a Case Report Jpn. J. Clin. Oncol., June 1, 2002; 32(6): 210 - 214. [Abstract] [Full Text] [PDF]

				S. Leij-Halfwerk, P. C Dagnelie, J W. O van den Berg, J D. L Wattimena, C. H Hordijk-Luijk, and J. P. Wilson Weight loss and elevated gluconeogenesis from alanine in lung cancer patients1 Am. J. Clinical Nutrition, February 1, 2000; 71(2): 583 - 589. [Abstract] [Full Text] [PDF]

				I. Lichter Review article : Weakness in terminal illness Palliative Medicine, April 1, 1990; 4(2): 73 - 80. [Abstract] [PDF]